TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by David Jones Pty Ltd to registration of trade mark application 1653738(35) and 1679107(44) - DAVID JONES PHARMACY - in the name of Pharmaline Pty Ltd
| Delegate: | Adrian Richards |
| Representation: | Opponent: Edward Heerey of Counsel instructed by Georgina Hey and Rebecca Brenikov of Norton Rose Fullbright Applicant: Andrew Fox of Counsel instructed by Alexandra Britt of Addisons |
| Decision: | 2018 ATMO 60 Trade Marks Act 1995 (Cth) – opposition to registration under section 52 – ground of opposition under section 60 pressed and established – applications refused |
Background
This decision with reasons concerns the opposition to registration of two trade marks (together, ‘the Trade Marks’) in the name of Pharmaline Pty Ltd (‘the Applicant’), the relevant details of which are set out below:
Application number: 1653738
Trade mark: DAVID JONES PHARMACY
Specification of services: Class 35: Pharmacy retail services
Priority date: 22 October 2014
Endorsement: Provisions of subsection s44(4) and/or Reg 4.15A(5) applied
(‘the Pharmacy Mark’)
Application number: 1679107
Trade Mark: DAVID JONES PHARMACY
Specification of services: Class 44: Medical advice for individuals with disabilities; Medical advisory services; Medical assistance; Medical care services; Medical clinic services; Medical counselling; Medical health assessment services; Medical screening; Medical services
Priority date: 5 March 2015
Endorsement: Provisions of subsection s44(4) and/or Reg 4.15A(5) applied
(‘the Medical Mark’)
After they had passed examination, in mid-2016 the Trade Marks were advertised as having been accepted for possible registration. In response to those advertisements, David Jones Pty Ltd (‘the Opponent’) filed a notice of intention to oppose and a statement of grounds and particulars against each of the Trade Marks.
In accordance with the statutory timetables for filing evidence, the Opponent filed evidence in support and the Applicant filed evidence in answer. The Opponent had the option to file evidence in reply but did not exercise it. After the period for filing evidence in reply ended, this office informed the parties that the oppositions were ready to be heard.
On 23 August 2017 the Opponent requested an oral hearing on the substantive matters. The oppositions to registration of the Trade Marks were accordingly set down for concurrent hearing on 2 March 2018.
I was allocated to conduct the hearing and decide the oppositions in my capacity as a delegate of the Registrar of Trade Marks. In preparation for the upcoming hearing, I wrote to the parties on 31 January 2018. This email primarily sought to draw the parties’ attention to the statutory requirement that each file a written outline of submissions in the lead up to the hearing proper.
The Opponent filed its outline of submissions precisely as was required. The Applicant, having had the advantage of reviewing the Opponent’s submissions before filing its own, took a different approach. When the time came for the Applicant’s outline of submissions to be filed, accompanying them was a pair of declarations. The more significant declaration was a copy of the evidence that the…
Keep reading for free
Create a free CaseChat account to read David Jones Pty Ltd v Pharmaline Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] ATMO 60
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the court were whether the Opponent's opposition to the Applicant's trade mark applications should succeed, and how to address the confidentiality claims made over the parties' evidence. The court was required to determine the extent to which it could refer to and rely upon the evidence presented, particularly in light of the statutory requirement to provide reasons for its decision that include findings on material questions of fact and the evidence upon which those findings are based.
The court acknowledged the difficulty in providing detailed reasons without referencing the evidence, which could contravene section 25D of the *Acts Interpretation Act 1901* (Cth). It noted that both parties had made broad claims of confidentiality over their statutory declarations. The court adopted an approach similar to previous decisions, stating that it would discuss commercially sensitive matters only to the extent necessary and that the parties' lack of specificity in their confidentiality claims had contributed to this challenge. The court then proceeded to discuss the evidence, including an overview of the Opponent's business and its use of the DAVID JONES trade marks, as well as the history of the Applicant's pharmacy business.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.